Simplify Genomics — Stock, Pipeline & Market Cap

Is this your company? Claim your profile to update info and connect with investors.

Private Company

Funding information not available

Overview

Simplify Genomics is a private, revenue-generating company founded in 2018 that operates at the intersection of diagnostics and software platform services. Its core offering is the Smart Genome™ Platform, an AI-informed system designed for high-speed querying of hundreds of millions of genomic variants, coupled with a clinical whole genome sequencing (WGS) reporting service. The company aims to make genomics central to primary care by providing clinicians with efficient, scalable tools for interpreting complex genomic data, covering hereditary risk, pharmacogenomics, and polygenic risk.

Genetics & Genomics

Technology Platform

Smart Genome™ Platform: An AI-informed genome search engine and clinical interpretation system. It combines a high-speed query interface for hundreds of millions of variants, a multi-source genomic data repository, and an AI-driven reporting engine to deliver clinical whole genome sequencing reports covering hereditary risk, pharmacogenomics, polygenic risk, and traits.

Opportunities

The rapid integration of genomics into primary care and the declining cost of whole genome sequencing present a massive growth opportunity.

The company can capitalize on this by licensing its platform to health systems lacking internal interpretation infrastructure and by expanding its clinical test menu.

Its aggregated data repository also creates opportunities for high-value research partnerships with pharmaceutical companies.

Risk Factors

The company faces intense competition from larger diagnostic firms and software providers.

Reimbursement for comprehensive whole genome sequencing reports, particularly for polygenic risk and wellness traits, remains uncertain and could limit market adoption.

Success is also dependent on continuous, costly curation of its genomic knowledge base to maintain clinical accuracy.

Competitive Landscape

Simplify Genomics competes in the crowded clinical genomics interpretation market. Key competitors include large sequencing companies with integrated software (e.g., Illumina), major diagnostic labs offering WGS (e.g., Labcorp, Quest), and specialized genomic interpretation software firms (e.g., Fabric Genomics, Genomenon). Its differentiation lies in the combination of a high-speed search engine with a fully accredited clinical reporting lab.

More companies in Diagnostics & Precision Medicine →More companies in United States →